Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 2
2021 3
2022 5
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Advances in drug treatments for mesothelioma.
Zucali PA, De Vincenzo F, Perrino M, Digiacomo N, Cordua N, D'Antonio F, Borea F, Fazio R, Pirozzi A, Santoro A. Zucali PA, et al. Among authors: cordua n. Expert Opin Pharmacother. 2022 Jun;23(8):929-946. doi: 10.1080/14656566.2022.2072211. Epub 2022 May 9. Expert Opin Pharmacother. 2022. PMID: 35508368
Systemic treatments for thymic tumors: a narrative review.
Zucali PA, De Vincenzo F, Perrino M, Digiacomo N, Cordua N, D'Antonio F, Borea F, Santoro A. Zucali PA, et al. Among authors: cordua n. Mediastinum. 2021 Sep 25;5:24. doi: 10.21037/med-21-11. eCollection 2021. Mediastinum. 2021. PMID: 35118329 Free PMC article. Review.
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy.
Perrino M, De Pas T, Bozzarelli S, Giordano L, De Vincenzo F, Conforti F, Digiacomo N, Cordua N, D'Antonio F, Borea F, Santoro A, Zucali PA. Perrino M, et al. Among authors: cordua n. Cancer. 2022 Feb 15;128(4):719-726. doi: 10.1002/cncr.33990. Epub 2021 Oct 27. Cancer. 2022. PMID: 34706060 Free article. Clinical Trial.
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy.
Lazzeri M, Duga S, Azzolini E, Fasulo V, Buffi N, Saita A, Lughezzani G, Paraboschi EM, Hurle R, Nobili A, Cecconi M, Guazzoni G, Casale P, Asselta R; Humanitas COVID-19 Task Force, The Humanitas Gavazzeni COVID-19 Task Force. Lazzeri M, et al. Minerva Urol Nephrol. 2022 Feb;74(1):77-84. doi: 10.23736/S2724-6051.20.04081-3. Epub 2021 Jan 13. Minerva Urol Nephrol. 2022. PMID: 33439572 Free article.
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
Conforti F, Zucali PA, Pala L, Catania C, Bagnardi V, Sala I, Della Vigna P, Perrino M, Zagami P, Corti C, Stucchi S, Barberis M, Guerini-Rocco E, Di Venosa B, De Vincenzo F, Cordua N, Santoro A, Giaccone G, De Pas TM. Conforti F, et al. Among authors: cordua n. Lancet Oncol. 2022 Oct;23(10):1287-1296. doi: 10.1016/S1470-2045(22)00542-3. Epub 2022 Sep 9. Lancet Oncol. 2022. PMID: 36096156 Clinical Trial.